From: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort
Variable | COPD cases (N = 121) | Smokers (N = 121) | p-value |
---|---|---|---|
Sex (male%) | 66 | 62 | N.S. |
Age (years)a | 57 ± 8 | 57 ± 8 | N.S. |
BMI (Kg/m2)a | 27 ± 5 | 28 ± 4 | N.S. |
Smoking habitc (pack-yrs)ac | 60 ± 25 | 44 ± 22 | <0.0001 |
Active smoking (%) | 50 | 64 | 0.027 |
T/S ratioa | 0.68 ± 0.25 | 0.88 ± 0.52 | <0.0001 |
FEV1 (L)a | 1.66 ± 0.7 | 2.9 ± 0.7 | <0.0001 |
FEV1 (% pred)a | 59 ± 21 | 101 ± 14 | <0.0001 |
FVC (% pred)a | 89 ± 22 | 108 ± 15 | <0.0001 |
FEV1 / FVC (%)a | 53 ± 12 | 76 ± 5 | <0.0001 |
PaO2 (mmHg)a | 72.3 ± 14.3 | 78.7 ± 10 | <0.001 |
KCO (%) | 79.6 ± 25.1 | 97.3 ± 21.3 | 0.001 |
IC/TLC (%) | 36 ± 9 | 45 ± 8 | <0.001 |
6MWD (m)a | 523 ± 89 | 551 ± 76 | 0.03 |
mMRC dyspneab | 1 (0–2) | 0 (0–0) | 0.006 |
BODE indexb | 1 (0–3) | 0 (0–1) | <0.001 |
Charlson indexb | 0 (0–1) | 0 (0–0) | N.S. |